S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
OTCMKTS:CRVW

CareView Communications (CRVW) Stock Price, News & Analysis

$0.05
0.00 (0.00%)
(As of 04/18/2024 ET)
Today's Range
$0.05
$0.05
50-Day Range
$0.05
$0.06
52-Week Range
$0.04
$0.10
Volume
200 shs
Average Volume
7,477 shs
Market Capitalization
$7.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CRVW stock logo

About CareView Communications Stock (OTCMKTS:CRVW)

CareView Communications, Inc. provides video monitoring solutions in the United States. Its products include CareView Patient Safety System, a video monitoring tool to improve the practice of nursing, create a better work environment, and make the patient's hospital stay more satisfying, which is used in hospitals, nursing homes, adult living centers, and outpatient care facilities; CareView Connect, which provides resident monitoring products and services for the long- term care industry; an array of wearable and stationary buttons that allow a resident to summon help either for an emergency or assistance; a mobile app capable of delivering an alert to the caregiver and allows them document information around that alert; and alert management and monitoring system, a suite of hardware and software that facilitate a data-driven solution for alert management and monitoring. The company also offers Caregiver Platform that offers caregiver connect mobile application to provide a convenient and intuitive interface to capture critical workflows, such as acknowledging and documenting alert presses by the resident. In addition, it provides SitterView and TeleMedView that allows hospital staff to use CareView's video cameras to observe and communicate with patients remotely. CareView Communications, Inc. is based in Lewisville, Texas.

CRVW Stock Price History

CRVW Stock News Headlines

Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
CRVW CareView Communications, Inc.
See More Headlines
Receive CRVW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareView Communications and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Radio & t.v. communications equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:CRVW
Previous Symbol
OTCBB:CRVW
Employees
56
Year Founded
N/A

Profitability

Net Income
$-3,950,000.00
Pretax Margin
-40.04%

Debt

Sales & Book Value

Annual Sales
$9.69 million
Book Value
($0.26) per share

Miscellaneous

Free Float
51,162,000
Market Cap
$7.73 million
Optionable
Not Optionable
Beta
0.31

Social Links

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Steven G. Johnson (Age 65)
    CEO, President, Secretary, Treasurer & Director
    Comp: $282.28k
  • Mr. Jason T. Thompson (Age 49)
    Principal Financial Officer, Chief Accounting Officer & Director
  • Ms. Sandra K. McRee (Age 68)
    Chief Operating Officer
    Comp: $224.28k
  • Mr. Derek del Carpio
    Chief Product & Technology Officer
  • Mr. Matthew E. Jackson Esq.
    General Counsel
  • Ms. Cathy Story MBA
    RN, Chief Clinical Officer
  • Mr. Chase Soong
    Controller

CRVW Stock Analysis - Frequently Asked Questions

How have CRVW shares performed in 2024?

CareView Communications' stock was trading at $0.0470 at the beginning of 2024. Since then, CRVW shares have increased by 13.7% and is now trading at $0.0535.
View the best growth stocks for 2024 here
.

When is CareView Communications' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our CRVW earnings forecast
.

What other stocks do shareholders of CareView Communications own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CareView Communications investors own include Alio Gold Inc. (ALO.TO) (ALO), First Majestic Silver (AG), United Cannabis (CNAB), Jack in the Box (JACK), Molecular Templates (MTEM), Mitsubishi UFJ Financial Group (MTU), TherapeuticsMD (TXMD), Zoetis (ZTS), Acxiom (ACXM) and Aldeyra Therapeutics (ALDX).

How do I buy shares of CareView Communications?

Shares of CRVW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CRVW) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners